PAVmed (PAVM) Assets Growth (1y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.59% |
| Jun 30, 2025 | 11.37% |
| Mar 31, 2025 | 41.79% |
| Dec 31, 2024 | -7.42% |
| Jun 30, 2024 | -26.58% |
| Mar 31, 2024 | -42.94% |
| Dec 31, 2023 | -38.65% |
| Sep 30, 2023 | -42.01% |
| Jun 30, 2023 | -34.89% |
| Mar 31, 2023 | -22.59% |
| Dec 31, 2022 | -37.94% |
| Sep 30, 2022 | 68.58% |
| Jun 30, 2022 | 74.06% |
| Mar 31, 2022 | 64.17% |
| Dec 31, 2021 | 339.76% |
| Sep 30, 2021 | 309.23% |
| Jun 30, 2021 | 433.34% |
| Mar 31, 2021 | 407.90% |
| Dec 31, 2020 | 173.18% |
| Sep 30, 2020 | 138.41% |
| Jun 30, 2020 | 25.80% |
| Mar 31, 2020 | 132.21% |
| Dec 31, 2019 | -14.79% |
| Sep 30, 2019 | -53.12% |
| Jun 30, 2019 | -37.17% |
| Mar 31, 2019 | 15.87% |
| Dec 31, 2018 | 418.18% |
| Sep 30, 2018 | 190.72% |
| Jun 30, 2018 | 4,861.63% |
| Mar 31, 2018 | 243.56% |
| Dec 31, 2017 | 88.38% |
| Sep 30, 2017 | 62.78% |
| Jun 30, 2017 | -92.82% |
| Mar 31, 2017 | 40.04% |
| Dec 31, 2016 | -28.31% |